Institut de Pharmacologie Moléculaire et Cellulaire and Institut de Neuro-Médecine Moléculaire, Unité Mixte de Recherche, 6097 Centre National de la Recherche Scientifique/Université de Nice-Sophia-Antipolis, Equipe labellisée Fondation pour la Recherche Médicale, 660 route des lucioles, Sophia-Antipolis, 06560 Valbonne, France.
Institute of Developmental Biology and Cancer, Unité Mixte de Recherche, 6543 Centre National de la Recherche Scientifique/Université de Nice-Sophia-Antipolis, Centre Antoine Lacassagne, 06189 Nice, France.
J Biol Chem. 2011 Aug 19;286(33):29192-29206. doi: 10.1074/jbc.M110.208249. Epub 2011 May 17.
The α-secretases A disintegrin and metalloprotease 10 (ADAM10) and ADAM17 trigger constitutive and regulated processing of the cellular prion protein (PrP(c)) yielding N1 fragment. The latter depends on protein kinase C (PKC)-coupled M1/M3 muscarinic receptor activation and subsequent phosphorylation of ADAM17 on its intracytoplasmic threonine 735. Here we show that regulated PrP(c) processing and ADAM17 phosphorylation and activation are controlled by the extracellular-regulated kinase-1/MAP-ERK kinase (ERK1/MEK) cascade. Thus, reductions of ERK1 or MEK activities by dominant-negative analogs, pharmacological inhibition, or genetic ablation all impair N1 secretion, whereas constitutively active proteins increase N1 recovery in the conditioned medium. Interestingly, we also observed an ERK1-mediated enhanced expression of PrP(c). We demonstrate that the ERK1-associated increase in PrP(c) promoter transactivation and mRNA levels involve transcription factor AP-1 as a downstream effector. Altogether, our data identify ERK1 as an important regulator of PrP(c) cellular homeostasis and indicate that this kinase exerts a dual control of PrP(c) levels through transcriptional and post-transcriptional mechanisms.
α-分泌酶去整合素和金属蛋白酶 10(ADAM10)和 ADAM17 触发细胞朊蛋白(PrP(c))的组成型和调节性加工,产生 N1 片段。后者依赖于蛋白激酶 C(PKC)偶联的 M1/M3 毒蕈碱受体激活,随后 ADAM17 胞内苏氨酸 735 磷酸化。在这里,我们表明调节型 PrP(c)加工和 ADAM17 磷酸化和激活受细胞外调节激酶-1/丝裂原活化蛋白激酶激酶(ERK1/MEK)级联控制。因此,ERK1 或 MEK 活性的显性负性类似物、药理学抑制或基因敲除的减少都损害了 N1 的分泌,而组成型活性蛋白增加了条件培养基中 N1 的恢复。有趣的是,我们还观察到 ERK1 介导的 PrP(c)表达增强。我们证明 ERK1 相关的 PrP(c)启动子转录激活和 mRNA 水平增加涉及转录因子 AP-1 作为下游效应物。总之,我们的数据确定 ERK1 是 PrP(c)细胞内稳态的重要调节剂,并表明该激酶通过转录和转录后机制对 PrP(c)水平施加双重控制。